[Yuekang Pharmaceutical: YKYY017 aerosol inhaler approved by FDA Clinical trial] Yuekang Pharmaceutical announced that the company recently received a letter from FDA approving the clinical trial of YKYY017 aerosol inhaler for the prevention and treatment of novel coronavirus infection.